Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to five years
Awards & highlights
Study Summary
This trial is testing a new cancer vaccine to see if it can prevent cancer recurrence.
Eligible Conditions
- Colon Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to five years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to five years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Disease-Free Survival
Secondary outcome measures
Overall Survival
Recurrence-Free Interval
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: OncoVAX and SurgeryExperimental Treatment2 Interventions
Autologous Specific Immunotherapy given intradermally following surgical resection of Stage II colon cancer
Group II: SurgeryActive Control1 Intervention
Surgical resection of Stage II colon cancer
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Surgery
2000
Completed Phase 3
~2550
Find a Location
Who is running the clinical trial?
Vaccinogen IncLead Sponsor
Michael G Hanna, Jr, PhDStudy ChairVaccinogen Inc
Rachel L Hoover, MS, MBAStudy DirectorVaccinogen Inc
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger